82 related articles for article (PubMed ID: 36911725)
1. Autologous Heat Shock Protein Peptide Vaccination for Newly Diagnosed Glioblastoma: Impact of Peripheral PD-L1 Expression on Response to Therapy.
Bloch O; Lim M; Sughrue ME; Komotar RJ; Abrahams JM; O'Rourke DM; D'Ambrosio A; Bruce JN; Parsa AT
Clin Cancer Res; 2017 Jul; 23(14):3575-3584. PubMed ID: 28193626
[No Abstract] [Full Text] [Related]
2. Therapeutic cancer vaccination against mutant calreticulin in myeloproliferative neoplasms induces expansion of specific T cells in the periphery but specific T cells fail to enrich in the bone marrow.
Holmström MO; Andersen M; Traynor S; Ahmad SM; Lisle TL; Handlos Grauslund J; Skov V; Kjær L; Ottesen JT; Gjerstorff MF; Hasselbalch HC; Andersen MH
Front Immunol; 2023; 14():1240678. PubMed ID: 37662956
[TBL] [Abstract][Full Text] [Related]
3. Novel Strategies for Peptide-Based Vaccines in Hematological Malignancies.
Klausen U; Holmberg S; Holmström MO; Jørgensen NGD; Grauslund JH; Svane IM; Andersen MH
Front Immunol; 2018; 9():2264. PubMed ID: 30327655
[TBL] [Abstract][Full Text] [Related]
4. Enhancing immune responses of ESC-based TAA cancer vaccines with a novel OMV delivery system.
Jin M; Huo D; Sun J; Hu J; Liu S; Zhan M; Zhang BZ; Huang JD
J Nanobiotechnology; 2024 Jan; 22(1):15. PubMed ID: 38166929
[TBL] [Abstract][Full Text] [Related]
5. The present and future of peptide vaccines for cancer: single or multiple, long or short, alone or in combination?
Slingluff CL
Cancer J; 2011; 17(5):343-50. PubMed ID: 21952285
[TBL] [Abstract][Full Text] [Related]
6. Cancer Immune Therapy for Philadelphia Chromosome-Negative Chronic Myeloproliferative Neoplasms.
Holmström MO; Hasselbalch HC; Andersen MH
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32630667
[TBL] [Abstract][Full Text] [Related]
7. An immunogenic first-in-human immune modulatory vaccine with PD-L1 and PD-L2 peptides is feasible and shows early signs of efficacy in follicular lymphoma.
Klausen U; Grønne Dahlager Jørgensen N; Grauslund JH; Munir Ahmad S; Gang AO; Martinenaite E; Weis-Banke SE; Breinholt MF; Novotny GW; Kjeldsen JW; Orebo Holmström M; Pedersen LB; Poulsen CB; Hansen PB; Met Ö; Svane IM; Niemann CU; Pedersen LM; Andersen MH
Oncoimmunology; 2021; 10(1):1975889. PubMed ID: 38283034
[TBL] [Abstract][Full Text] [Related]
8. Designing a SARS-CoV-2 T-Cell-Inducing Vaccine for High-Risk Patient Groups.
Rammensee HG; Gouttefangeas C; Heidu S; Klein R; Preuß B; Walz JS; Nelde A; Haen SP; Reth M; Yang J; Tabatabai G; Bösmüller H; Hoffmann H; Schindler M; Planz O; Wiesmüller KH; Löffler MW
Vaccines (Basel); 2021 Apr; 9(5):. PubMed ID: 33923363
[TBL] [Abstract][Full Text] [Related]
9. Case Report: Long-Term Survival of a Patient with Cerebral Metastasized Ovarian Carcinoma Treated with a Personalized Peptide Vaccine and Anti-PD-1 Therapy.
Zelba H; Kyzirakos C; Kayser S; Shao B; Reinhardt A; Pieper N; Rabsteyn A; Döcker D; Armeanu-Ebinger S; Kloor M; Hadaschik D; Schulze M; Battke F; Golf A; Biskup S
Vaccines (Basel); 2024 Apr; 12(4):. PubMed ID: 38675779
[TBL] [Abstract][Full Text] [Related]
10. Arginase-1 specific CD8+ T cells react toward malignant and regulatory myeloid cells.
Glöckner HJ; Martinenaite E; Landkildehus Lisle T; Grauslund J; Ahmad S; Met Ö; Thor Straten P; Hald Andersen M
Oncoimmunology; 2024; 13(1):2318053. PubMed ID: 38404966
[TBL] [Abstract][Full Text] [Related]
11. Revisiting Circulating Extracellular Matrix Fragments as Disease Markers in Myelofibrosis and Related Neoplasms.
Hasselbalch HC; Junker P; Skov V; Kjær L; Knudsen TA; Larsen MK; Holmström MO; Andersen MH; Jensen C; Karsdal MA; Willumsen N
Cancers (Basel); 2023 Aug; 15(17):. PubMed ID: 37686599
[TBL] [Abstract][Full Text] [Related]
12. Oncogenic JAK2
Prestipino A; Emhardt AJ; Aumann K; O'Sullivan D; Gorantla SP; Duquesne S; Melchinger W; Braun L; Vuckovic S; Boerries M; Busch H; Halbach S; Pennisi S; Poggio T; Apostolova P; Veratti P; Hettich M; Niedermann G; Bartholomä M; Shoumariyeh K; Jutzi JS; Wehrle J; Dierks C; Becker H; Schmitt-Graeff A; Follo M; Pfeifer D; Rohr J; Fuchs S; Ehl S; Hartl FA; Minguet S; Miething C; Heidel FH; Kröger N; Triviai I; Brummer T; Finke J; Illert AL; Ruggiero E; Bonini C; Duyster J; Pahl HL; Lane SW; Hill GR; Blazar BR; von Bubnoff N; Pearce EL; Zeiser R
Sci Transl Med; 2018 Feb; 10(429):. PubMed ID: 29467301
[TBL] [Abstract][Full Text] [Related]
13. Arginase-1 targeting peptide vaccine in patients with metastatic solid tumors - A phase I trial.
Lorentzen CL; Martinenaite E; Kjeldsen JW; Holmstroem RB; Mørk SK; Pedersen AW; Ehrnrooth E; Andersen MH; Svane IM
Front Immunol; 2022; 13():1023023. PubMed ID: 36330525
[TBL] [Abstract][Full Text] [Related]
14. Peptide emulsions in incomplete Freund's adjuvant create effective nurseries promoting egress of systemic CD4
Melssen MM; Fisher CT; Slingluff CL; Melief CJM
J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36939214
[TBL] [Abstract][Full Text] [Related]
15. Immune modulations during chemoimmunotherapy & novel vaccine strategies--in metastatic melanoma and non small-cell lung cancer.
Iversen TZ
Dan Med J; 2013 Dec; 60(12):B4774. PubMed ID: 24355457
[TBL] [Abstract][Full Text] [Related]
16. An arginase1- and PD-L1-derived peptide-based vaccine for myeloproliferative neoplasms: A first-in-man clinical trial.
Grauslund JH; Holmström MO; Martinenaite E; Lisle TL; Glöckner HJ; El Fassi D; Klausen U; Mortensen REJ; Jørgensen N; Kjær L; Skov V; Svane IM; Hasselbalch HC; Andersen MH
Front Immunol; 2023; 14():1117466. PubMed ID: 36911725
[TBL] [Abstract][Full Text] [Related]
17. Peptide Vaccination Against PD-L1 With IO103 a Novel Immune Modulatory Vaccine in Multiple Myeloma: A Phase I First-in-Human Trial.
Jørgensen NG; Klausen U; Grauslund JH; Helleberg C; Aagaard TG; Do TH; Ahmad SM; Olsen LR; Klausen TW; Breinholt MF; Hansen M; Martinenaite E; Met Ö; Svane IM; Knudsen LM; Andersen MH
Front Immunol; 2020; 11():595035. PubMed ID: 33240282
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
